Latest filing published 21 May 2026 for ClearPoint Neuro, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Pascal E. R. Girin in ClearPoint Neuro, Inc., where the filings describe the role as board member. Between 31 December 2015 and 19 May 2026, the trades on record add up to 26 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 21 May 2026: an option exercise, in ClearPoint Neuro, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations